Lilly acquisition of Akouos : American pharmaceutical giant Eli Lilly and Company (Lilly) has agreed to acquire precision genetic medicine company Akouos in a cash deal worth about $487 million. Headquartered in Boston and founded in 2016, Akouos is focused on developing a portfolio of advanced adeno-associated viral gene therapies to treat inner ear conditions, […]
Pipeline Therapeutics has initiated a phase 1/2a trial of PIPE-505, which is a small molecule gamma secretase inhibitor (GSI), in patients who have sensorineural hearing loss (SNHL) associated with hearing speech in noisy environments. The phase 1/2a trial is anticipated to take in 24 adult patients, and will be carried out as a randomized, double-blind, […]
